GovChime
Awarded

6505--Atorvastatin CA Tablets - Radha Pharmaceuticals

Awarded tounder 36E79723D0025 (source: SAM.gov award notice)• $72.3M

Overview

Posted
July 19, 2023
Notice type
Award Notice

Notice details

Last updated
Sep 9, 2025
Award date
Jul 18, 2023
Award amount (SAM.gov award notice)
$72.3M

Identifiers

Solicitation number
36E79723R0015
Notice ID
3634145df91448529ce1303ceb5512b2
Award number (PIID)
36E79723D0025

Description

Continuation of SF-1449, Block 3: The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period. Contract Award/Effective Date: ___________________ Implementation Period: __________________________ Ordering Period (Base Year): _____________________ Offerors shall not enter information into the above fields. Continuation of SF-1449, Blocks 19 through 24: Line items 1, 3, 5, and 7 are unit of use. All unit-of-use packaging identified in the Schedule of Supplies (i.e. 90s) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. To be considered for award, offerors must submit a price for line items 1, 2A or 2B, 3, 4A or 4B, 5, 6A or 6B, 7, and 8A or 8B for the base year and all four option years. One award will be made in the aggregate for line items 1, 2A or 2B, 3, 4A or 4B, 5, 6A or 6B, 7, and 8A or 8B for the base year and all four option years. Offered prices shall not exceed two decimal places. Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application. Line Item 1 Atorvastatin Calcium Tablets, 10MG, 90 Tablets per Bottle (Unit of Use) NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 229,724 Bottles $_________ $__________ Option Year One 229,724 Bottles $_________ $__________ Option Year Two 229,724 Bottles $_________ $__________ Option Year Three 229,724 Bottles $_________ $__________ Option Year Four 229,724 Bottles $_________ $__________ _____________________________________________________________________________________________ Line Item 2A Atorvastatin Calcium Tablets, 10MG, 500 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 99,872 Bottles $_________ $__________ Option Year One 99,872 Bottles $_________ $__________ Option Year Two 99,872 Bottles $_________ $__________ Option Year Three 99,872 Bottles $_________ $__________ Option Year Four 99,872 Bottles $_________ $__________ OR Line Item 2B Atorvastatin Calcium Tablets, 10MG, 1,000 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 49,936 Bottles $_________ $__________ Option Year One 49,936 Bottles $_________ $__________ Option Year Two 49,936 Bottles $_________ $__________ Option Year Three 49,936 Bottles $_________ $__________ Option Year Four 49,936 Bottles $_________ $__________ Line Item 3 Atorvastatin Calcium Tablets, 20MG, 90 Tablets per Bottle (Unit of Use) NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 448,352 Bottles $_________ $__________ Option Year One 448,352 Bottles $_________ $__________ Option Year Two 448,352 Bottles $_________ $__________ Option Year Three 448,352 Bottles $_________ $__________ Option Year Four 448,352 Bottles $_________ $__________ Line Item 4A Atorvastatin Calcium Tablets, 20MG, 500 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 177,834 Bottles $_________ $__________ Option Year One 177,834 Bottles $_________ $__________ Option Year Two 177,834 Bottles $_________ $__________ Option Year Three 177,834 Bottles $_________ $__________ Option Year Four 177,834 Bottles $_________ $__________ OR Line Item 4B Atorvastatin Calcium Tablets, 20MG, 1,000 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 88,917 Bottles $_________ $__________ Option Year One 88,917 Bottles $_________ $__________ Option Year Two 88,917 Bottles $_________ $__________ Option Year Three 88,917 Bottles $_________ $__________ Option Year Four 88,917 Bottles $_________ $__________ ___________________________________________________________________________________________ Line Item 5 Atorvastatin Calcium Tablets, 40MG, 90 Tablets per Bottle (Unit of Use) NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 568,269 Bottles $_________ $__________ Option Year One 568,269 Bottles $_________ $__________ Option Year Two 568,269 Bottles $_________ $__________ Option Year Three 568,269 Bottles $_________ $__________ Option Year Four 568,269 Bottles $_________ $__________ ________________________________________________________________________________________ Line Item 6A Atorvastatin Calcium Tablets, 40MG, 500 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 264,822 Bottles $_________ $__________ Option Year One 264,822 Bottles $_________ $__________ Option Year Two 264,822 Bottles $_________ $__________ Option Year Three 268,822 Bottles $_________ $__________ Option Year Four 268,822 Bottles $_________ $__________ OR Line Item 6B Atorvastatin Calcium Tablets, 40MG, 1,000 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 132,411 Bottles $_________ $__________ Option Year One 132,411 Bottles $_________ $__________ Option Year Two 132,411 Bottles $_________ $__________ Option Year Three 132,411 Bottles $_________ $__________ Option Year Four 132,411 Bottles $_________ $__________ Line Item 7 Atorvastatin Calcium Tablets, 80MG, 90 Tablets per Bottle (Unit of Use) NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 522,721 Bottles $_________ $__________ Option Year One 522,721 Bottles $_________ $__________ Option Year Two 522,721 Bottles $_________ $__________ Option Year Three 522,721 Bottles $_________ $__________ Option Year Four 522,721 Bottles $_________ $__________ ________________________________________________________________________________________ Line Item 8A Atorvastatin Calcium Tablets, 80MG, 500 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 234652 Bottles $_________ $__________ Option Year One 234,652 Bottles $_________ $__________ Option Year Two 234,652 Bottles $_________ $__________ Option Year Three 234,652 Bottles $_________ $__________ Option Year Four 234,652 Bottles $_________ $__________ OR Line Item 8B Atorvastatin Calcium Tablets, 80MG, 1,000 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 117,326 Bottles $_________ $__________ Option Year One 117,326 Bottles $_________ $__________ Option Year Two 117,326 Bottles $_________ $__________ Option Year Three 117,326 Bottles $_________ $__________ Option Year Four 117,326 Bottles $_________ $__________

Full description on SAM.gov

Award Overview

Award Number

36E79723D0025

Award Amount (SAM.gov award notice)

$72.3M

Award Date

Jul 18, 2023

Awardee

Awardee UEI

C1S5SQ88KY67

Original Solicitation

Notice ID: 3634145df91448529ce1303ceb5512b2

Posted Date: Jul 19, 2023

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • 36E79722D0035
    RADHA PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Nov 6, 2026
  • 36E79723D0029
    RADHA PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Oct 28, 2026
  • 36E79725D0043
    RADHA PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Sep 14, 2026
  • 36E79725D0044
    RADHA PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Sep 11, 2026
  • 36E79726D0013
    RADHA PHARMACEUTICALS INC
    Department of Veterans AffairsNAICS 325412
    —Signed Sep 11, 2026

Contacts

Documents

No documents available.

Lifecycle

Solicitation:36E79723R0015
  1. Pre-Solicitation
  2. Solicitation
  3. Awarded

This opportunity has been awarded.

  1. Pre-SolicitationApr 6, 2023

    6505--Atorvastatin Calcium Tablets

    Notice 124c5799c2d0458894bfe29b3a68ba3c on SAM.gov

  2. 4×
    SolicitationApr 25, 2023

    6505--Atorvastatin Calcium Tablets

    Notice 5c36851e8fab4d6399eb4ba9d6dc9838 on SAM.gov

  3. AwardedCurrentJul 19, 2023

    6505--Atorvastatin CA Tablets - Radha Pharmaceuticals

    Notice 3634145df91448529ce1303ceb5512b2 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

36E79723R0015

Archive Date

Sep 17, 2023

Office Address

HINES, IL, 60141